Sorafenib Maintenance Post-Transplantation for FLT3-ITD Acute Myeloid Leukemia
Sorafenib maintenance showed positive relapse, survival, and safety outcomes for patients with FLT3-ITD acute myeloid leukemia after transplantation.
Home
Effects of 5-Azacitidine Dose Changes With Myelodysplastic Syndrome
For patients with myelodysplastic syndrome, 5-azacitidine treatment delays showed some links to outcomes, while dose reductions had less impact.
Analysis of Carfilzomib vs Bortezomib Triplet Therapy for Newly Diagnosed Multiple Myeloma
The superiority of carfilzomib vs bortezomib in triplet therapy was compared in newly diagnosed multiple myeloma ineligible for immediate transplantation.
Siltuximab for Patients With Idiopathic Multicentric Castleman Disease
Researchers evaluated an approach to treatment guided by histopathologic subtype in patients with idiopathic multicentric Castleman disease.
How Doctors Can Cope With Psychological Distress During the Pandemic
When talking about work issues, Dr Bernstein recommends trying not to focus too much on how awful things are because it can be disheartening.
FDA Requires Boxed Warning Update for Benzodiazepines
Benzodiazepines are widely used to treat a variety of conditions including anxiety disorders, insomnia and seizures.
Red Blood Cell Distribution Width, Mortality Tied in COVID-19
Elevated RDW and increase in RDW during hospitalization linked to increased mortality risk.
Survey Finds Variation in Practice Patterns for Neuroimaging in Sickle Cell Anemia
Survey finds variation in practice patterns for obtaining MRI/MRA for stroke prevention and monitoring in patients with sickle cell anemia.
Gene-Corrected Hematopoietic Stem Cells Show Potential for Engraftment in Fanconi Anemia
Autologous transplantation with gene-corrected hematopoietic stem cells show engraftment and proliferation in nonconditioned patients with Fanconi anemia.
BCMA-Directed CAR T-Cell Therapy Gets Priority Review for Multiple Myeloma
The BLA is supported by data from the open-label, single-arm phase 2 KarMMa study.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
